Sunday, November 28

COVID-19 Vaccine: FDA Authorizes Doses of Pfizer for Children 5-11 Years

The United States Authorized Pfizer-BioNTech’s COVID-19 Vaccine for Children Ages Five to 11 Years on Friday, paving the way for a new stage in the immunization campaign that concerns 28 million people.

This emergency authorization granted by the Federal Agency for Medicines (FDA) came after a careful review of clinical trial results performed by Pfizer on several thousand children.

“As a mother and as a physician, I know that parents, caregivers, teachers and children have been eagerly awaiting this authorization,” said Janet Woodcock, acting FDA commissioner, in a statement.

Vaccinating young children against COVID-19 is an additional step towards returning to normalcy“he added.

A committee of independent experts on Tuesday endorsed the immunization of children between the ages of five and 11 with the Pfizer vaccine, which in clinical trials showed an efficacy of 90.7% in preventing symptomatic forms of COVID-19 in that age group.

Before inoculation begins, a committee of experts from the Centers for Disease Control and Prevention (CDC) will meet next week to provide input and publish recommendations; final step of the process.



Read also

Leave a Reply

Your email address will not be published. Required fields are marked *